Literature DB >> 11023820

Receptor-activity-modifying protein 1 forms heterodimers with two G-protein-coupled receptors to define ligand recognition.

K Leuthäuser1, R Gujer, A Aldecoa, R A McKinney, R Muff, J A Fischer, W Born.   

Abstract

Receptor-activity-modifying proteins (RAMPs) with single transmembrane domains define the function of two G-protein-coupled receptors of the B family. Cell-surface complexes of human RAMP1 (hRAMP1) and human calcitonin (CT) receptor isotype 2 (hCTR2) or rat CT-receptor-like receptor (rCRLR) have now been identified through protein cross-linking, co-immunoprecipitation and confocal microscopy. They are two distinct CT-gene-related peptide (CGRP) receptors coupled to cAMP production and pharmacologically distinguished by the CT and CGRP antagonists salmon CT(8-32) and human or rat CGRP(8-37). Thus direct molecular interactions of hRAMP1 with hCTR2 or rCRLR are required for CGRP recognition. hCTR2, moreover, adopts non-traditional functions through its association with hRAMP1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023820      PMCID: PMC1221370     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  16 in total

1.  RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.

Authors:  L M McLatchie; N J Fraser; M J Main; A Wise; J Brown; N Thompson; R Solari; M G Lee; S M Foord
Journal:  Nature       Date:  1998-05-28       Impact factor: 49.962

2.  Identification of brain isoforms of the rat calcitonin receptor.

Authors:  P M Sexton; S Houssami; J M Hilton; L M O'Keeffe; R J Center; M T Gillespie; P Darcy; D M Findlay
Journal:  Mol Endocrinol       Date:  1993-06

3.  Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain.

Authors:  C P Chang; R V Pearse; S O'Connell; M G Rosenfeld
Journal:  Neuron       Date:  1993-12       Impact factor: 17.173

4.  Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.

Authors:  G Christopoulos; K J Perry; M Morfis; N Tilakaratne; Y Gao; N J Fraser; M J Main; S M Foord; P M Sexton
Journal:  Mol Pharmacol       Date:  1999-07       Impact factor: 4.436

5.  The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor.

Authors:  N J Fraser; A Wise; J Brown; L M McLatchie; M J Main; S M Foord
Journal:  Mol Pharmacol       Date:  1999-06       Impact factor: 4.436

6.  A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1.

Authors:  N Bühlmann; K Leuthäuser; R Muff; J A Fischer; W Born
Journal:  Endocrinology       Date:  1999-06       Impact factor: 4.736

7.  Mouse receptor-activity-modifying proteins 1, -2 and -3: amino acid sequence, expression and function.

Authors:  K Husmann; P M Sexton; J A Fischer; W Born
Journal:  Mol Cell Endocrinol       Date:  2000-04-25       Impact factor: 4.102

8.  hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery.

Authors:  T Dennis; A Fournier; A Cadieux; F Pomerleau; F B Jolicoeur; S St Pierre; R Quirion
Journal:  J Pharmacol Exp Ther       Date:  1990-07       Impact factor: 4.030

Review 9.  Calcitonin.

Authors:  P M Sexton; D M Findlay; T J Martin
Journal:  Curr Med Chem       Date:  1999-11       Impact factor: 4.530

10.  Distinct binding sites for calcitonin gene-related peptide and salmon calcitonin in rat central nervous system.

Authors:  H Henke; F A Tschopp; J A Fischer
Journal:  Brain Res       Date:  1985-12-23       Impact factor: 3.252

View more
  10 in total

1.  Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes.

Authors:  R J Bailey; C S Walker; A H Ferner; K M Loomes; G Prijic; A Halim; L Whiting; A R J Phillips; D L Hay
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 3.  Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25.

Authors:  Debbie L Hay; Michael L Garelja; David R Poyner; Christopher S Walker
Journal:  Br J Pharmacol       Date:  2017-11-28       Impact factor: 8.739

Review 4.  Class II G protein-coupled receptors and their ligands in neuronal function and protection.

Authors:  Bronwen Martin; Rakel Lopez de Maturana; Randall Brenneman; Tom Walent; Mark P Mattson; Stuart Maudsley
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 5.  Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development.

Authors:  Rebekah L Bower; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2016-05-18       Impact factor: 8.739

6.  Preparation and characterization of PEGylated amylin.

Authors:  Luiz Henrique Guerreiro; Mariana F A N Guterres; Bruno Melo-Ferreira; Luiza C S Erthal; Marcela da Silva Rosa; Daniela Lourenço; Priscilla Tinoco; Luís Maurício T R Lima
Journal:  AAPS PharmSciTech       Date:  2013-07-02       Impact factor: 3.246

7.  Amylin acts in the central nervous system to increase sympathetic nerve activity.

Authors:  Caroline Fernandes-Santos; Zhongming Zhang; Donald A Morgan; Deng-Fu Guo; Andrew F Russo; Kamal Rahmouni
Journal:  Endocrinology       Date:  2013-05-03       Impact factor: 4.736

8.  Neuronal receptor activity-modifying protein 1 promotes energy expenditure in mice.

Authors:  Zhongming Zhang; Xuebo Liu; Donald A Morgan; Adisa Kuburas; Daniel R Thedens; Andrew F Russo; Kamal Rahmouni
Journal:  Diabetes       Date:  2011-02-25       Impact factor: 9.461

9.  Dissection of functional residues in receptor activity-modifying proteins through phylogenetic and statistical analyses.

Authors:  Alfonso Benítez-Páez; Sonia Cárdenas-Brito
Journal:  Evol Bioinform Online       Date:  2008-04-28       Impact factor: 1.625

10.  Calcitonin gene-related peptide alters the firing rates of hypothalamic temperature sensitive and insensitive neurons.

Authors:  Daniel C Braasch; Erin M Deegan; Eleanor R Grimm; John D Griffin
Journal:  BMC Neurosci       Date:  2008-07-11       Impact factor: 3.288

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.